AERI Financials 07/21/2014 22:38:52
Aerie Pharmaceuticals, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Total Revenue - - -
Cost of Revenue - - -
Gross Profit - - -
Operating Expenses
Research and Development 11,883 9,273 10,695
Sales, General and Admin. 10,287 5,020 3,521
Non-Recurring Items - - -
Other - - -
Operating Income (22,170) (14,293) (14,216)
Income From Continuing Operations
Add'l Income/Expense Items (8,978) (685) 1,249
Earnings Before Interest and Tax (31,148) (14,978) (12,967)
Interest Expense - - -
Earnings Before Tax (31,148) (14,978) (12,967)
Income Tax - - -
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (31,148) (14,978) (12,967)
Non Recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (31,148) (14,978) (12,967)
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders (31,598) (15,643) (13,419)
Aerie Pharmaceuticals, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Total Revenue - - -
Cost of Revenue - - -
Gross Profit - - -
Operating Expenses
Research and Development 11,883 9,273 10,695
Sales, General and Admin. 10,287 5,020 3,521
Non-Recurring Items - - -
Other - - -
Operating Income (22,170) (14,293) (14,216)
Income From Continuing Operations
Add'l Income/Expense Items (8,978) (685) 1,249
Earnings Before Interest and Tax (31,148) (14,978) (12,967)
Interest Expense - - -
Earnings Before Tax (31,148) (14,978) (12,967)
Income Tax - - -
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (31,148) (14,978) (12,967)
Non Recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (31,148) (14,978) (12,967)
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders (31,598) (15,643) (13,419)
